Association between renin‐angiotensin antagonism and COVID‐19–related mortality in patients with essential hypertension: A single center, retrospective cohort study

Abstract There is conflicting evidence in select mouse models and humans that suggest angiotensin‐converting enzyme 2 expression is increased due to treatment with angiotensin converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARBs). Given the wide range of conditions that these me...

詳細記述

書誌詳細

主要な著者:	Vijayvardhan Kamalumpundi, Shuntaro Kawasaki, Linhai Cheng, Erin E. Meyers, Elham Shams, Ologibe Ofori, Assim Eddin, Marcelo L. G. Correia
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2024-09-01
シリーズ:	The Journal of Clinical Hypertension
主題:	ACE2 COVID‐19 hypertension renin‐angiotensin antagonism
オンライン･アクセス:	https://doi.org/10.1111/jch.14869
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!